DK1162956T3 - Sammensætninger og fremgangsmåder til forbedring af integritet af kompromitterede legemskanaler og - kaviteter - Google Patents

Sammensætninger og fremgangsmåder til forbedring af integritet af kompromitterede legemskanaler og - kaviteter

Info

Publication number
DK1162956T3
DK1162956T3 DK00906091T DK00906091T DK1162956T3 DK 1162956 T3 DK1162956 T3 DK 1162956T3 DK 00906091 T DK00906091 T DK 00906091T DK 00906091 T DK00906091 T DK 00906091T DK 1162956 T3 DK1162956 T3 DK 1162956T3
Authority
DK
Denmark
Prior art keywords
integrity
improving
methods
compositions
cavities
Prior art date
Application number
DK00906091T
Other languages
English (en)
Inventor
Pierre E Signore
Lindsay S Machan
Original Assignee
Angiotech Int Ag
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiotech Int Ag, Univ British Columbia filed Critical Angiotech Int Ag
Application granted granted Critical
Publication of DK1162956T3 publication Critical patent/DK1162956T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Epoxy Resins (AREA)
  • Saccharide Compounds (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Treatment Of Sludge (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00906091T 1999-02-23 2000-02-23 Sammensætninger og fremgangsmåder til forbedring af integritet af kompromitterede legemskanaler og - kaviteter DK1162956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12142499P 1999-02-23 1999-02-23
PCT/CA2000/000175 WO2000050016A2 (en) 1999-02-23 2000-02-23 Compositions and methods for improving integrity of compromised body passageways and cavities

Publications (1)

Publication Number Publication Date
DK1162956T3 true DK1162956T3 (da) 2005-10-10

Family

ID=22396646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906091T DK1162956T3 (da) 1999-02-23 2000-02-23 Sammensætninger og fremgangsmåder til forbedring af integritet af kompromitterede legemskanaler og - kaviteter

Country Status (16)

Country Link
US (3) US20020022055A1 (da)
EP (1) EP1162956B8 (da)
JP (1) JP2002537324A (da)
KR (1) KR20010112285A (da)
CN (1) CN1344156A (da)
AT (1) ATE297198T1 (da)
AU (1) AU768527B2 (da)
CA (1) CA2369739C (da)
DE (1) DE60020681T9 (da)
DK (1) DK1162956T3 (da)
ES (1) ES2243232T3 (da)
IL (2) IL145069A0 (da)
NO (1) NO20014085L (da)
NZ (1) NZ513895A (da)
PT (1) PT1162956E (da)
WO (1) WO2000050016A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569129B1 (en) * 2000-09-13 2003-05-27 Mayo Foundation For Medical Education And Research Biological revascularization
CA2423061A1 (en) * 2000-09-25 2002-03-28 Cohesion Technologies, Inc. Resorbable anastomosis stents and plugs
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
WO2003094937A1 (en) * 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
JP2006515186A (ja) * 2002-09-26 2006-05-25 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 血管周囲ラップ
CA2511484A1 (en) * 2002-12-30 2004-07-22 Angiotech International Ag Silk-containing stent graft
WO2005065079A2 (en) 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
WO2005112569A2 (en) * 2004-05-13 2005-12-01 Medtronic Vascular, Inc. Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel
US20070100321A1 (en) * 2004-12-22 2007-05-03 Leon Rudakov Medical device
WO2006124021A1 (en) * 2005-05-12 2006-11-23 Angiotech International Ag Compositions and methods for treating diverticular disease
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
ES2882702T3 (es) * 2016-07-29 2021-12-02 Univ Tohoku Células "Muse" como agente profiláctico o terapéutico para el aneurisma
WO2019060697A1 (en) 2017-09-22 2019-03-28 Becton, Dickinson And Company 4% TRISODIC CITRATE SOLUTION FOR USE AS A CATHETER LOCK SOLUTION
JP2020536955A (ja) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド 治療剤の制御放出のための埋込み可能なデポー
EP3737433A1 (en) * 2018-01-08 2020-11-18 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
WO2019221853A1 (en) 2018-05-12 2019-11-21 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
EP3843710A1 (en) 2018-08-28 2021-07-07 Foundry Therapeutics, Inc. Polymer implants

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797485A (en) * 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
US4978668A (en) * 1986-09-02 1990-12-18 Purdue Research Foundation Treatment to reduce ischemic tissue injury
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
AU6747790A (en) * 1989-11-13 1991-06-13 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ATE188375T1 (de) * 1992-11-17 2000-01-15 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
CN1502331A (zh) * 1993-07-19 2004-06-09 Ѫ�ܼ���ҩ�﹫˾ 抗血管生长组合物及使用方法
ES2255477T5 (es) * 1993-07-29 2010-04-08 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Uso de paclitaxel y sus derivados en la fabricacion de un medicamento para el tratamiento de reestenosis.
ATE220894T1 (de) * 1993-12-29 2002-08-15 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5977163A (en) * 1996-03-12 1999-11-02 Pg-Txl Company, L. P. Water soluble paclitaxel prodrugs
WO1998057671A2 (en) * 1997-06-18 1998-12-23 Boston Scientific Corporation Polycarbonate-polyurethane dispersions for thrombo-resistant coatings
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US5997875A (en) * 1998-03-27 1999-12-07 Zhou; James H. Herbal composition and treatment methods

Also Published As

Publication number Publication date
EP1162956B8 (en) 2005-08-10
EP1162956B1 (en) 2005-06-08
EP1162956A2 (en) 2001-12-19
IL145069A (en) 2007-06-03
JP2002537324A (ja) 2002-11-05
US20030124197A1 (en) 2003-07-03
WO2000050016A9 (en) 2001-10-11
WO2000050016A2 (en) 2000-08-31
CN1344156A (zh) 2002-04-10
DE60020681T9 (de) 2006-08-31
WO2000050016A3 (en) 2001-01-18
KR20010112285A (ko) 2001-12-20
AU2787800A (en) 2000-09-14
ES2243232T3 (es) 2005-12-01
AU768527B2 (en) 2003-12-18
CA2369739A1 (en) 2000-08-31
ATE297198T1 (de) 2005-06-15
US20020022055A1 (en) 2002-02-21
PT1162956E (pt) 2005-10-31
NZ513895A (en) 2001-09-28
DE60020681T2 (de) 2006-05-11
NO20014085D0 (no) 2001-08-22
CA2369739C (en) 2008-12-16
NO20014085L (no) 2001-10-22
US20070104767A1 (en) 2007-05-10
DE60020681D1 (de) 2005-07-14
IL145069A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
NO20014085L (no) Blandinger og fremgangsmåter for forbedring av integritet av kompromitterte kroppspassasjer og hulrom
DE60031248D1 (de) Elektroaktive pore
DK1487493T3 (da) Konjugater af cytotoksiske midler og biologisk aktive peptider
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
CY1106733T1 (el) Αγωγη νευρολογικης δυσλειτουργιας περιλαμβανουσα σουλφαμικες φρουκτοπυρανοζες και ερυθροποιητινη
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE60239707D1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0967987T3 (da) Sammensætning til behandling af tumorer indeholdende hajbruskekstrakter og anitneoplastiske stoffer
ITBO20000453A0 (it) Apparecchiatura e procedimento per la sterilizzazione del terreno .
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
AU6469401A (en) Pharmaceutically active compounds and methods of use
IL161501A0 (en) Methods of preventing and treating flavivirus infection in animals
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
WO2003059332A3 (en) Use of an anti-microtubule agent for the treatment of uveitis
EP1568363A3 (en) Compositions and methods for improving integrity of compromised body passageways and cavities
AU4643501A (en) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke